• SCUBE3 Antibody Targeting in Cancer Progression

  2026-09-23

  The reference study identifies secreted SCUBE3 as a multifunctional cancer dependency linking oncogenic receptor signaling, DNA repair, therapy resistance, and immune suppression. Its neutralizing antibody strategy inhibited tumor growth and metastasis in preclinical models by disrupting SCUBE3-associated signaling through FOXR2 and c-Myc while restoring antitumor immune gene expression.

• CFDA-SE for Cell Proliferation Tracking

  2026-09-22

  CFDA-SE converts intracellular esterase activity into a division-resolved fluorescence record for lymphocytes, fibroblasts, NK cells, bacteria, and migrating populations. Paired with CD38 surfaceome mapping, it distinguishes proliferation history from surface-protein proximity and helps build more informative functional assays.

• Paroxetine Mesylate: From SSRI to Translational Asset

  2026-09-22

  Paroxetine Mesylate is more than a serotonin transporter probe. Its combination of high-affinity SERT engagement, CYP2D6 inhibition, and reported MET/ERBB3 pathway activity creates a disciplined opportunity for drug-repurposing research—provided investigators separate clinically relevant exposure from exploratory micromolar oncology biology.

• DMG-PEG2000-NH2: Workflow for LNP Linkers

  2026-09-21

  DMG-PEG2000-NH2 combines a primary amine for selective conjugation with a PEG-lipid architecture suited to liposomes and LNP research. This guide connects amide-coupling chemistry, siRNA encapsulation, particle characterization, and troubleshooting while using the reference study to sharpen assay selection and translational interpretation.

• Bestatin Hydrochloride: Practical Research Workflows

  2026-09-21

  Bestatin hydrochloride, also known as Ubenimex, gives researchers a practical way to probe aminopeptidase N/CD13 and aminopeptidase B in cell, angiogenesis, and neuropeptide assays. This guide converts mechanistic evidence into workable setup, dosing, controls, and troubleshooting strategies for cancer research and peptide-processing studies.

• Liposomal Ce6 PDT Drives Pyroptosis in Breast Cancer

  2026-09-20

  A 2024 study shows that liposomal Chlorin e6 photodynamic therapy can convert mitochondrial oxidative injury into caspase-1-associated pyroptosis and immunogenic tumor-cell death. In a 4T1 breast cancer model, combining this approach with checkpoint inhibition strengthened tumor control and immune-cell infiltration, while also highlighting important translational limitations.

• Dihydrotestosterone Workflows for AR Signaling

  2026-09-19

  Dihydrotestosterone enables controlled androgen receptor activation in cancer, signaling, and muscle physiology studies. This practical guide connects concentration-defined cell assays with microenvironment and ALS-model applications while emphasizing solvent control, pathway-specific readouts, and troubleshooting.

• Erlotinib as a Mechanistic Probe of SCUBE3–EGFR

  2026-09-18

  Erlotinib and NSC 718781 provide a precise pharmacologic lens for separating EGFR kinase dependence from SCUBE3-driven tumor biology. This guide translates recent SCUBE3 findings into better-designed signaling, proliferation, apoptosis, and immune-context assays.

• Small Molecules Improve Pancreatic Ductal Organoids

  2026-09-18

  Liao and colleagues developed a small-molecule culture strategy that improves the initiation and long-term expansion of pancreatic ductal organoids while retaining heterogeneous ductal and acinar populations. The model offers a practical platform for studying pancreatic exocrine biology, ductal–acinar plasticity, pancreatic disease mechanisms, and future drug-screening workflows.

• Chenodeoxycholic Acid for FXR Renal Injury Studies

  2026-09-17

  Use Chenodeoxycholic Acid to connect FXR activation with KLF11 transcription and JAK2/STAT3 suppression in contrast-induced kidney injury models. This practical guide covers solution preparation, cell and mouse workflows, causal controls, and troubleshooting for mechanism-focused CDCA experiments.

• CXCR4–EGFR Heteromers Rewire Signaling

  2026-09-17

  Comez and colleagues show that CXCR4 and EGFR form ligand-sensitive oligomeric signaling complexes rather than functioning only as independent receptors. NanoBRET and nanobody-based proximity ligation assays connect receptor proximity with altered Gi, PLCγ, and β-arrestin-2 coupling, including at endogenous receptor levels in HeLa cells.

• JZL184: Selective MAGL Inhibitor Guide

  2026-09-16

  JZL184 is a potent monoacylglycerol lipase inhibitor that increases 2-arachidonoylglycerol signaling through MAGL blockade. Preclinical evidence links this mechanism to CB1 receptor-mediated synaptic modulation, analgesia, hypomotility, hypothermia, and anxiolytic-like behavioral effects.

• SHC-1 Inhibition and CFTR Surface Trafficking

  2026-09-16

  Barros and colleagues show that MAPK/SHC-1-dependent CFTR internalization is detectable across CFBE, 16HBE, and Caco-2 epithelial models, but pharmacological SHC-1 inhibition increases surface CFTR only in CFBE cells. The accompanying changes in GLUT1 and E-cadherin indicate that apparent trafficking rescue may be cell-context dependent and not fully selective.

• Gingerenone A Restores Sunitinib Sensitivity in RCC

  2026-09-15

  A January 2026 study identifies gingerenone A as a metabolic inhibitor that targets LDHA-driven glycolysis and improves sunitinib activity in renal cell carcinoma models. Its combination of computational prediction, biochemical validation, metabolic rescue experiments, and in vivo testing supports a mechanism linking lactate metabolism to HIF-1α-dependent angiogenic signaling and tyrosine kinase inhibitor resistance.

• ALC-0315 LNP Workflow for mRNA Tracking

  2026-09-15

  Use ALC-0315 to build controlled lipid nanoparticles for intracellular mRNA transport, then connect formulation QC with whole-body measurement of antigen expression. This workflow distinguishes where an mRNA-LNP travels from whether its payload produces protein, helping researchers optimize therapeutic mRNA delivery and vaccine studies.

8186 records 1/546 page Next 12345 下5页 Last page